Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia.

× No keyword cloud information.

27 in total

1. t(15;17) Reverse transcription-polymerase chain reaction with alternative splicing.

Authors: R K Rolston; J A Kant
Journal: J Mol Diagn Date: 2001-08 Impact factor: 5.568

2. Extramedullary relapse confirmed by fluorescence in situ hybridization study of an ear mass in acute promyelocytic leukemia.

Authors: Keun-Wook Lee; Jongyoun Yi; Tak Yun; Dae-Young Kim; Dong Soon Lee; Sung Sup Park; Han Ik Cho; Sung-Soo Yoon; Seonyang Park; Byoung Kook Kim; Noe Kyeong Kim
Journal: Int J Hematol Date: 2004-06 Impact factor: 2.490

3. Recurrent extramedullary relapse of acute promyelocytic leukemia after allogeneic stem cell transplantation: successful treatment by arsenic trioxide in combination with local radiotherapy.

Authors: Tatsuyuki Kai; Hideo Kimura; Yutaka Shiga; Kazuei Ogawa; Hisashi Sato; Yukio Maruyama
Journal: Int J Hematol Date: 2006-05 Impact factor: 2.490

Review 4. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.

Authors: Miguel A Sanz; Pierre Fenaux; Martin S Tallman; Elihu H Estey; Bob Löwenberg; Tomoki Naoe; Eva Lengfelder; Hartmut Döhner; Alan K Burnett; Sai-Juan Chen; Vikram Mathews; Harry Iland; Eduardo Rego; Hagop Kantarjian; Lionel Adès; Giuseppe Avvisati; Pau Montesinos; Uwe Platzbecker; Farhad Ravandi; Nigel H Russell; Francesco Lo-Coco
Journal: Blood Date: 2019-02-25 Impact factor: 22.113

5. Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation.

Authors: Bruno Paiva; Maria-Belén Vidriales; Jorge Cerveró; Gema Mateo; Jose J Pérez; Maria A Montalbán; Anna Sureda; Laura Montejano; Norma C Gutiérrez; Alfonso García de Coca; Natalia de Las Heras; Maria V Mateos; Maria C López-Berges; Raimundo García-Boyero; Josefina Galende; Jose Hernández; Luis Palomera; Dolores Carrera; Rafael Martínez; Javier de la Rubia; Alejandro Martín; Joan Bladé; Juan J Lahuerta; Alberto Orfao; Jesús F San Miguel
Journal: Blood Date: 2008-07-31 Impact factor: 22.113

6. Treatment of Acute Promyelocytic Leukemia with Single Agent Arsenic Trioxide: Experience from a Tertiary Care Center in India.

Authors: Karthik Udupa; Joseph Thomas; Chethana Babu Udupa; V S Binu; Prahlad Sharan
Journal: Indian J Hematol Blood Transfus Date: 2016-03-24 Impact factor: 0.900

Review 7. Frontline treatment of acute myeloid leukemia in adults.

Authors: Gevorg Tamamyan; Tapan Kadia; Farhad Ravandi; Gautam Borthakur; Jorge Cortes; Elias Jabbour; Naval Daver; Maro Ohanian; Hagop Kantarjian; Marina Konopleva
Journal: Crit Rev Oncol Hematol Date: 2016-12-11 Impact factor: 6.312

8. A bcr-3 isoform of RARalpha-PML potentiates the development of PML-RARalpha-driven acute promyelocytic leukemia.

Authors: J L Pollock; P Westervelt; A K Kurichety; P G Pelicci; J L Grisolano; T J Ley
Journal: Proc Natl Acad Sci U S A Date: 1999-12-21 Impact factor: 11.205

Review 9. Management of acute promyelocytic leukemia.

Authors: Martin S Tallman; Chadi Nabhan
Journal: Curr Oncol Rep Date: 2002-09 Impact factor: 5.075

10. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.

Authors: Majid Momeny; Majid Zakidizaji; Reza Ghasemi; Ahmad R Dehpour; Maryam Rahimi-Balaei; Yassan Abdolazimi; Ardeshir Ghavamzadeh; Kamran Alimoghaddam; Seyed H Ghaffari
Journal: Med Oncol Date: 2009-09-10 Impact factor: 3.064